BioNTech SE on X: "+++ Omicron BA.4/BA.5 vaccine update +++ The FDA today granted Emergency Use Authorization (EUA) of a 30-µg booster dose of our Omicron BA.4/BA.5 bivalent vaccine, as a booster
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
Study asks why uptake of bivalent COVID boosters low
U.S. clears updated Pfizer, Moderna COVID-19 boosters targeting newest variants
FDA let Pfizer, Moderna seek BA.5 booster approval without key data | Fortune
Moderna booster candidate shows strong response against Omicron subvariants | Reuters
New Covid booster shots don't protect better against omicron BA.5, studies find
Vaccini COVID aggiornati Omicron: quali sono? Chi può farli?
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine
Pfizer seeks FDA authorization for omicron vaccine in kids under 5 | The Hill
BioNTech SE on X: "A booster dose of our Omicron BA.4/BA.5-adapted bivalent #COVID19 vaccine developed with @Pfizer has been recommended for marketing authorization by the @EMA_News' #CHMP for children 5-11. https://t.co/COyxj9fKS4 https://t.co ...
FDA Authorizes New Covid Boosters Aimed at Omicron Subvariants
BioNTech SE on X: "We announced today with @Pfizer updated 30-day data for the 30-µg booster dose of our Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine. https://t.co/h2ZEfBpuNb https://t.co/oaOxsYgPSk" / X
Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Coronavirus e vaccinazioni - Centro Sanitario Valposchiavo
BioNTech SE on X: "We completed, together with @Pfizer, the submission to the @US_FDA requesting Emergency Use Authorization (EUA) of a 10-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for
Pfizer Covid Vaccine Protects Against Omicron Sublineages BA.4 and BA.5: Study - Bloomberg
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut
FDA approves 2nd omicron booster for high-risk people
RACGP - Updating COVID-19 vaccines 'on the agenda', but not sustainable
Updated Covid-19 booster shots expanded to children as young as 5 | CNN
